A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation
International Journal of Radiation Oncology*Biology*Physics · 2024-04 · 118 (5) · 1282-1293
DOI: 10.1016/j.ijrobp.2023.10.025 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-04. Verfasst von Alexander Rühle und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Freiburg - Medical Center, Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, …. Hauptthemen laut MEDLINE: Cisplatin, Head and Neck Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz Zentrum München, Ludwig-Maximilians-Universität München, University of Leipzig Faculty of Medicine.
Abstract (Originalsprache)
PURPOSE: The number of older adults with head and neck squamous cell carcinoma (HNSCC) is increasing, and treatment of these patients is challenging. Although cisplatin-based chemotherapy concomitantly with radiation therapy is considered the standard regimen for patients with locoregionally advanced HNSCC, there is substantial real-world heterogeneity regarding concomitant chemotherapy in older patients with HNSCC. METHODS AND MATERIALS: The SENIOR study is an international multicenter cohort study including older patients (≥65 years) with HNSCC treated with definitive radiation therapy at 13 academic centers in the United States and Europe. Patients with concomitant chemoradiation were analyzed regarding overall survival (OS) and progression-free survival (PFS) via Kaplan-Meier analyses. Fine-Gray competing risk regressions were performed regarding the incidence of locoregional failures and distant metastases. RESULTS: Six hundred ninety-seven patients with a median age of 71 years were included in this analysis. Single-agent cisplatin was the most common chemotherapy regimen (n = 310; 44%), followed by cisplatin plus 5-fluorouracil (n = 137; 20%), carboplatin (n = 73; 10%), and mitomycin C plus 5-fluorouracil (n = 64; 9%). Carboplatin-based regimens were associated with diminished PFS (hazard ratio [HR], 1.39 [1.03-1.89]; P .05). The median cumulative dose of cisplatin was 180 mg/m2 (IQR, 120-200 mg/m2). Cumulative cisplatin doses ≥200 mg/m2 were associated with increased OS (HR, 0.71 [0.53-0.95]; P = .02), increased PFS (HR, 0.66 [0.51-0.87]; P = .003), and lower incidence of locoregional failures (subdistribution HR, 0.50 [0.31-0.80]; P = .004). Higher cumulative cisplatin doses remained an independent prognostic variable in the multivariate regression analysis for OS (HR, 0.996 [0.993-0.999]; P = .009). CONCLUSIONS: Single-agent cisplatin can be considered in the standard chemotherapy regimen for older patients with HNSCC who can tolerate cisplatin. Cumulative cisplatin doses are prognostically relevant in older patients with HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Freiburg - Medical Center, Freiburg, Germany; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department…
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
- Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK) Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen…
- Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Department of Radiation Oncology, Charité - Universitätsmedizin Berlin; Freie Universität Berlin, Humboldt-Universität zu Berlin; and Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK) Partner…
Förderung
- Helmholtz Zentrum München
- Ludwig-Maximilians-Universität München
- University of Leipzig Faculty of Medicine
- Universität Leipzig
- Varian Medical Systems
- Deutschen Konsortium für Translationale Krebsforschung
Zitieren
APA
Rühle, A., Weymann, M., Behrens, M., Marschner, S., Haderlein, M., Fabian, A., Senger, C., Dickstein, D. R., Kraft, J., von der Grün, J., Chen, E., Aquino-Michaels, T., Domschikowski, J., Bickel, A., Altay-Langguth, A., Kalinauskaite, G., Lewitzki, V., Bonomi, M., Blakaj, D. M., …, & Nicolay, N. H. (2024). A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics, 118(5), 1282-1293. https://doi.org/10.1016/j.ijrobp.2023.10.025
Vancouver
Rühle A, Weymann M, Behrens M, Marschner S, Haderlein M, Fabian A, et al. A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 2024;118(5):1282-1293. doi:10.1016/j.ijrobp.2023.10.025
BibTeX
@article{Rhle2024,
author = {Rühle, Alexander and Weymann, Maria and Behrens, Max and Marschner, Sebastian and Haderlein, Marlen and Fabian, Alexander and Senger, Carolin and Dickstein, Daniel R and Kraft, Johannes and von der Grün, Jens and Chen, Eric and Aquino-Michaels, Todd and Domschikowski, Justus and Bickel, Amanda and Altay-Langguth, Alev and Kalinauskaite, Goda and Lewitzki, Victor and Bonomi, Marcelo and Blakaj, Dukagjin M and Jhawar, Sachin R and Baliga, Sujith and Barve, Rahul and Ferentinos, Konstantinos and Zamboglou, Constantinos and Schnellhardt, Sören and Haehl, Erik and Spohn, Simon K B and Kuhnt, Thomas and Zöller, Daniela and Guckenberger, Matthias and Budach, Volker and Belka, Claus and Bakst, Richard and Mayer, Arnulf and Schmidberger, Heinz and Grosu, Anca-Ligia and Balermpas, Panagiotis and Stromberger, Carmen and Nicolay, Nils H},
title = {A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
volume = {118},
number = {5},
pages = {1282--1293},
doi = {10.1016/j.ijrobp.2023.10.025}
}
EUVIMED